Viral factors and outcome of chronic hepatitis B revisited François HabersetzerRémy Moenne-LoccozThomas F. Baumert Editorial 11 September 2013 Pages: 945 - 947
The prediction of immunological dysfunction during antiviral therapy for HCV after liver transplantation: can we improve outcomes? Ji-Yuan ZhangYuan-Yuan LiFu-Sheng Wang Editorial 17 October 2013 Pages: 948 - 950
Human parenchymal and non-parenchymal liver cell isolation, culture and characterization Georg DammElisa PfeifferThomas S. Weiss Review Article 10 October 2013 Pages: 951 - 958
Angiogenesis in liver regeneration and fibrosis: “a double-edged sword” Savneet KaurK. Anita Review Article 09 November 2013 Pages: 959 - 968
HBsAg, HBeAg and HBV DNA level changes and precore/basal core promoter mutations in the natural history of chronic hepatitis B in Indonesian patients TuryadiMeta Dewi ThedjaDavid Handojo Muljono Original Article 23 May 2013 Pages: 969 - 980
Therapeutic potential of a combined hepatitis B virus surface and core antigen vaccine in patients with chronic hepatitis B Mamun Al-MahtabSheikh Mohammad Fazle AkbarSalimur Rahman Original Article 09 November 2013 Pages: 981 - 989
Immunological dysfunction during or after antiviral therapy for recurrent hepatitis C reduces graft survival Pratima SharmaAmy HosmerAnna S. Lok Original Article 25 April 2013 Pages: 990 - 999
The virological response in Koreans infected with HCV genotype 1 did not differ between groups treated with a full dose or reduced dose (≥80 % full dose) of peginterferon alfa-2a: a prospective randomized multicenter trial Jung Hyun KwonSi Hyun BaeHyeon Woo Yim Original Article 23 October 2013 Pages: 1000 - 1009
Incidence and risk factors for surveillance failure in patients with regular hepatocellular carcinoma surveillance Dong Hyun SinnJieun YiByung Chul Yoo Original Article 27 July 2013 Pages: 1010 - 1018
Familial clustering of hepatocellular carcinoma in HBsAg-positive patients in the United States Myron John TongThatcher Thi HuynhSurachate Siripongsakun Original Article 17 July 2013 Pages: 1019 - 1029
Clinical features and natural history of portal vein thrombosis after radiofrequency ablation for hepatocellular carcinoma in Japan Taro ShimadaHitoshi MaruyamaOsamu Yokosuka Original Article 28 August 2013 Pages: 1030 - 1039
Elevated ALT and GGT predict all-cause mortality and hepatocellular carcinoma in Taiwanese male: a case-cohort study Ruben HernaezHsin-Chieh YehJeanne M. Clark Original Article 17 October 2013 Pages: 1040 - 1049
Circulating free DNA in the progression of liver damage to hepatocellular carcinoma Marika PiciocchiRomilda CardinFabio Farinati Original Article 02 November 2013 Pages: 1050 - 1057
Value of the APASL severity score in patients with acute variceal bleeding: a single center experience Go Heun KimJeong Han KimChang Hong Lee Original Article 29 August 2013 Pages: 1058 - 1064
Hedgehog signaling influences gender-specific response of liver to radiation in mice Sihyung WangKeumju LeeYoungmi Jung Original Article 27 July 2013 Pages: 1065 - 1074
Multiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluation Silvia GaiaAntonella OliveroCorrado Tarella Original Article 11 October 2013 Pages: 1075 - 1083
Hepatocytes of cirrhotic rat liver accumulate glycogen more slowly than normal ones Natalia N. BezborodkinaSergey V. OkovityBoris N. Kudryavtsev Original Article 23 July 2013 Pages: 1084 - 1090
